140 related articles for article (PubMed ID: 7638206)
1. Physical mapping of the minimal region of loss in 5q- chromosome.
Fairman J; Chumakov I; Chinault AC; Nowell PC; Nagarajan L
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7406-10. PubMed ID: 7638206
[TBL] [Abstract][Full Text] [Related]
2. Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q- chromosome.
Nagarajan L; Zavadil J; Claxton D; Lu X; Fairman J; Warrington JA; Wasmuth JJ; Chinault AC; Sever CE; Slovak ML
Blood; 1994 Jan; 83(1):199-208. PubMed ID: 8274735
[TBL] [Abstract][Full Text] [Related]
3. 5q- chromosome. Evidence for complex interstitial breaks in a case of refractory anemia with excess blasts.
Nagarajan L; Zhao L; Lu X; Warrington JA; Wasmuth JJ; Siciliano M; Deisseroth AB; Liang JC
Cancer Genet Cytogenet; 1994 May; 74(1):8-12. PubMed ID: 8194054
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases.
Le Beau MM; Espinosa R; Neuman WL; Stock W; Roulston D; Larson RA; Keinanen M; Westbrook CA
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5484-8. PubMed ID: 8516290
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of the 5q- chromosome.
Nagarajan L
Leuk Lymphoma; 1995 May; 17(5-6):361-6. PubMed ID: 7549826
[TBL] [Abstract][Full Text] [Related]
6. Spectral karyotypic study of the HL-60 cell line: detection of complex rearrangements involving chromosomes 5, 7, and 16 and delineation of critical region of deletion on 5q31.1.
Liang JC; Ning Y; Wang RY; Padilla-Nash HM; Schröck E; Soenksen D; Nagarajan L; Ried T
Cancer Genet Cytogenet; 1999 Sep; 113(2):105-9. PubMed ID: 10484974
[TBL] [Abstract][Full Text] [Related]
7. Translocations and deletions of 5q13.1 in myelodysplasia and acute myelogenous leukemia: evidence for a novel critical locus.
Fairman J; Wang RY; Liang H; Zhao L; Saltman D; Liang JC; Nagarajan L
Blood; 1996 Sep; 88(6):2259-66. PubMed ID: 8822947
[TBL] [Abstract][Full Text] [Related]
8. Isolation of yeast artificial chromosomes containing the entire transcriptional unit of the human FGF1 gene: a 720-kb contig spanning human chromosome 5q31.3-->q32.
Chiu IM; Liu Y; Payson RA
Cancer Genet Cytogenet; 1998 Oct; 106(1):1-10. PubMed ID: 9772902
[TBL] [Abstract][Full Text] [Related]
9. Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map.
Zhao N; Stoffel A; Wang PW; Eisenbart JD; Espinosa R; Larson RA; Le Beau MM
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6948-53. PubMed ID: 9192672
[TBL] [Abstract][Full Text] [Related]
10. Construction of a yeast artificial chromosome contig encompassing the human acidic fibroblast growth factor (FGF1) gene: toward the cloning of the ANLL/MDS tumor-suppressor gene.
Chiu IM; Gilmore EC; Liu Y; Payson RA
Genomics; 1994 Feb; 19(3):552-60. PubMed ID: 7514571
[TBL] [Abstract][Full Text] [Related]
11. Deletions of chromosome 5q13.3 and 17p loci cooperate in myeloid neoplasms.
Castro PD; Liang JC; Nagarajan L
Blood; 2000 Mar; 95(6):2138-43. PubMed ID: 10706886
[TBL] [Abstract][Full Text] [Related]
12. Loss of the chromosomal region 5q11-q31 in the myeloid cell line HL-60: characterization by comparative genomic hybridization and fluorescence in situ hybridization.
Shipley J; Weber-Hall S; Birdsall S
Genes Chromosomes Cancer; 1996 Mar; 15(3):182-6. PubMed ID: 8721684
[TBL] [Abstract][Full Text] [Related]
13. Localization of SMAD5 and its evaluation as a candidate myeloid tumor suppressor.
Hejlik DP; Kottickal LV; Liang H; Fairman J; Davis T; Janecki T; Sexton D; Perry W; Tavtigian SV; Teng DH; Nagarajan L
Cancer Res; 1997 Sep; 57(17):3779-83. PubMed ID: 9288787
[TBL] [Abstract][Full Text] [Related]
14. Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint.
Boultwood J; Fidler C; Lewis S; Kelly S; Sheridan H; Littlewood TJ; Buckle VJ; Wainscoat JS
Genomics; 1994 Feb; 19(3):425-32. PubMed ID: 8188284
[TBL] [Abstract][Full Text] [Related]
15. Smad5, a tumor suppressor candidate at 5q31.1, is hemizygously lost and not mutated in the retained allele in human leukemia cell line HL60.
Zavadil J; Brezinová J; Svoboda P; Zemanová Z; Michalová K
Leukemia; 1997 Aug; 11(8):1187-92. PubMed ID: 9264367
[TBL] [Abstract][Full Text] [Related]
16. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
Volkert S; Kohlmann A; Schnittger S; Kern W; Haferlach T; Haferlach C
Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299
[TBL] [Abstract][Full Text] [Related]
17. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.
Willman CL; Sever CE; Pallavicini MG; Harada H; Tanaka N; Slovak ML; Yamamoto H; Harada K; Meeker TC; List AF
Science; 1993 Feb; 259(5097):968-71. PubMed ID: 8438156
[TBL] [Abstract][Full Text] [Related]
18. Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion.
Boultwood J; Rack K; Kelly S; Madden J; Sakaguchi AY; Wang LM; Oscier DG; Buckle VJ; Wainscoat JS
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6176-80. PubMed ID: 1829836
[TBL] [Abstract][Full Text] [Related]
19. A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes.
MacKinnon RN; Kannourakis G; Wall M; Campbell LJ
Cancer Genet; 2011 Apr; 204(4):187-94. PubMed ID: 21536236
[TBL] [Abstract][Full Text] [Related]
20. Deletions of chromosome 5 in malignant myeloid disorders.
Le Beau MM
Cancer Surv; 1992; 15():143-59. PubMed ID: 1451109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
